Sahpra News Updates

Pretoria, 22 May 2025 –The South African Health Products Regulatory Authority (SAHPRA), having applied Reliance on the World Health Organization (WHO) PQ assessment under Emergency Use Listing, has listed the first mpox (monkeypox) in vitro diagnostic (IVD). This serves as an important step in improving global access to mpox testing by using a reliance process. The emergency use approval of the Alinity m... The post SAHPRA Approves First… Read more »

Pretoria, 04 April 2025 –The South African Health Products Regulatory Authority (SAHPRA) has joined the Medical Device Single Audit Programme (MDSAP), an international audit programme of medicines and medical device regulators aimed at improving efficiencies in the regulation of medical device manufacturers by engaging in work... The post SAHPRA joins the Medical… Read more »

Pretoria, 24 March 2025 –The South African Health Products Regulatory Authority (SAHPRA), in partnership with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of the Witwatersrand, proudly announces the graduation of the fourth cohort from the Clinical Assessors Short Course —... The post SAHPRA Strengthens Regulatory… Read more »

The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of Interests (EOIs) since 2023, and these have all been closed. Updates on EOIs: Download PDF The post Update: Feedback on SAHPRA’s EOIs and latest appointments appeared first on SAHPRA. Read more »

Cairo, Egypt, 4 February 2025: The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency – New Partnership for Africa’s Development (AUDA-NEPAD) are proud to announce the signing of a Memorandum of Understanding (MoU) among Africa’s WHO Maturity Level 3... The post Landmark agreement among… Read more »

Pretoria – The leading agencies, the South African Health Products Regulatory Authority (SAHPRA) and the National Department of Health (NDoH) with identified key stakeholders for the National Action Plan (NAP) are in a three-day workshop this week (4-6 February 2025) to pilot the World Health... The post South Africa-WHO gears… Read more »

Pretoria, 17 January 2025 – The South African Health Products Regulatory Authority (SAHPRA) has recommended that the product information of medroxyprogesterone acetate (MPA)-containing products be amended by updating the safety warnings to include the potential risk of meningioma. MPA is a synthetic oral and injectable... The post SAHPRA clarifies the… Read more »

The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation’s telephone system has been restored. SAHPRA apologises for any inconvenience this may have caused. The post Telephone system has been restored appeared first on SAHPRA. Read more »

The South African Health Products Regulatory Authority (SAHPRA) wishes to inform stakeholders that the organisation is currently experiencing a technical issue with its telephone system, which is affecting both outgoing and incoming calls. The Authority’s service provider is working diligently to resolve the issue as... The post Temporary telephone system… Read more »

Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavilable today, 29 November 2024 due to the organisation’s Annual General Meeting. If you require assistance, please use applicable contacts from Key Contacts: https://www.sahpra.org.za/key-contacts/ The post SAHPRA Offices will be unavailable on 29 November 2024… Read more »